Product category:
Lab automation equipment and robotics
News Release from: The Automation Partnership
Edited by the Laboratorytalk Editorial
Team on 28 February 2002
Ron Long takes TAP deputy chair
Former Amersham CEO to help drive The Automation Partnership's growing genomics automation business
The Automation Partnership (TAP), manufacturers of advanced automated systems, announces the appointment of Ron Long as deputy chairman In this role, Ron will help to advance TAP's business in life science research technologies where his vision, and experience are unrivalled
This article was originally published on Laboratorytalk on 17 May 2002 at 8.00am (UK)
Related stories
uHTS specification agreement
Ultra high throughput screening platform for drug discovery platform is capable of delivering several hundred thousand screening wells per day with a variety of assay technologies
Multi-format cell dispenser
System operates interchangeably across the range of micro-well plate formats without manual intervention and provides the high precision and accuracy required in today's screening laboratory
Ron will help leverage TAP's robotic platform technologies including BasePlate for PCR set up, HomeBase for protein crystallisation, and management of DNA libraries for clinical studies.
Ron brings extensive industry knowledge and expertise to TAP.
Most recently, he was vice chairman of the life sciences group at Amersham until he retired in June 2001.
He joined Amersham in August 1990 as commercial director, was then appointed managing director of life sciences in 1996 and became CEO for Amersham Pharmacia Biotech from 1997 until June 2000.
According to TAP's chief executive Richard Archer, "Ron has made an outstanding contribution to the life sciences industry.
His drive and vision will be key to growing TAP's genomics business into a position of global leadership.
Ron's successful experience will be a critical factor in further building TAP's genomics business in both the existing and emerging applications in genomics and high throughput drug discovery." Prior to Amersham, Ron worked for 22 years with the Wellcome Foundation, holding divisional director appointments in Wellcome Biotechnology, Coopers Animal Health, and as group managing director of Calmic International.
Ron currently holds non executive positions in Kudos Pharmaceuticals, Pharmagene, and Gyros.
• The Automation Partnership: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
